Improving participation in cancer clinical trials at Weill Cornell Medicine.
Official title: Optimization of strategies to improve NCI-sponsored clinical trial participation throughout the Weill Cornell Medicine - Meyer Cancer Center Sphere
Funded at Weill Medical Coll of Cornell Univ · NIH-10977161 · Data updated 2026-11-12
This study is all about finding better ways to help cancer patients in New York City join clinical trials, so they can access new treatments and support, no matter where they live.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 13, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $194,778 |
| NIH project number | 1R50CA285498-01A1 |
| Project ID | NIH-10977161 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients residing in the catchment area of the Meyer Cancer Center who may benefit from participation in clinical trials.
✕Less likely to help
Patients who are not diagnosed with cancer or those who are unable to participate in clinical trials due to medical or logistical reasons may not benefit from this research.
What this research studies
This research focuses on enhancing the participation of patients in NCI-sponsored clinical trials at the Weill Cornell Medicine - Meyer Cancer Center. The approach involves optimizing strategies to engage a diverse patient population across multiple locations, including Manhattan, Brooklyn, and Queens. By identifying barriers to participation and implementing targeted outreach efforts, the research aims to increase awareness and accessibility of clinical trials for cancer patients. The methodology includes collaboration with various cancer research networks and leveraging existing infrastructure to facilitate patient enrollment.
Why it matters
Potential benefit: If successful, this research could lead to increased participation in clinical trials, providing patients with access to cutting-edge cancer therapies and improving treatment outcomes.
How similar studies have gone: Previous research has shown success in improving clinical trial participation through targeted outreach and engagement strategies, indicating that this approach is both tested and promising.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Tagawa, Scott T — Weill Medical Coll of Cornell Univ
- Study coordinator: Tagawa, Scott T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.